Skip to main content

Peer Review reports

From: Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn’s disease: a Chinese real-world study

Original Submission
3 Aug 2021 Submitted Original manuscript
11 Aug 2021 Reviewed Reviewer Report - Davide Giuseppe Ribaldone
4 Sep 2021 Reviewed Reviewer Report
13 Sep 2021 Author responded Author comments - Min Zhi
15 Sep 2021 Author responded Author comments - Min Zhi
Resubmission - Version 2
13 Sep 2021 Submitted Manuscript version 2
17 Sep 2021 Reviewed Reviewer Report - Davide Giuseppe Ribaldone
27 Sep 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
28 Sep 2021 Editorially accepted
18 Oct 2021 Article published 10.1186/s12876-021-01946-8

You can find further information about peer review here.

Back to article page